APA (7th ed.) Citation

B, G., KM, D., M, V., M, H., M, T., BP, G., . . . R, D. (2025). Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial. Science translational medicine, 17(792), eadi4505. https://doi.org/10.1126/scitranslmed.adi4505

Chicago Style (17th ed.) Citation

B, Gomez-Mancilla, et al. "Mavoglurant Reduces Cocaine Use in Patients with Cocaine Use Disorder in a Phase 2 Clinical Trial." Science Translational Medicine 17, no. 792 (2025): eadi4505. https://doi.org/10.1126/scitranslmed.adi4505.

MLA (9th ed.) Citation

B, Gomez-Mancilla, et al. "Mavoglurant Reduces Cocaine Use in Patients with Cocaine Use Disorder in a Phase 2 Clinical Trial." Science Translational Medicine, vol. 17, no. 792, 2025, p. eadi4505, https://doi.org/10.1126/scitranslmed.adi4505.